electroCore, Inc. (ECOR)Healthcare | Medical Devices | Rockaway, United States | NasdaqCM
6.50 USD
-0.18
(-2.695%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 6.50 Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:57 a.m. EDT
ECOR shows volatile J-shaped recovery momentum leading into the April 15 investor day, yet the fundamental outlook remains bearish due to persistent losses, negative equity, and a lowered analyst target, making it a high-risk speculative trade rather than an investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.101360 |
| AutoETS | 0.101404 |
| AutoARIMA | 0.101405 |
| MSTL | 0.119112 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.671 |
| Excess Kurtosis | -0.59 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 3.776 |
| Market Cap | 52,543,128 |
| Forward P/E | -11.82 |
| Beta | 0.60 |
| Profit Margins | -43.60% |
| Website | https://www.electrocore.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.0015360713 |
| Address1 | 200 Forge Way |
| Address2 | Suite 205 |
| All Time High | 303.75 |
| All Time Low | 2.925 |
| Ask | 6.89 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 69,410 |
| Average Daily Volume3 Month | 67,845 |
| Average Volume | 67,845 |
| Average Volume10Days | 69,410 |
| Beta | 0.596 |
| Bid | 6.47 |
| Bid Size | 1 |
| Book Value | -0.214 |
| City | Rockaway |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.5 |
| Current Ratio | 1.381 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 7.04 |
| Day Low | 6.45 |
| Display Name | electroCore |
| Earnings Call Timestamp End | 1,773,952,200 |
| Earnings Call Timestamp Start | 1,773,952,200 |
| Earnings Timestamp | 1,773,950,400 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | -12,652,000 |
| Ebitda Margins | -0.39498 |
| Enterprise To Ebitda | -3.978 |
| Enterprise To Revenue | 1.571 |
| Enterprise Value | 50,335,128 |
| Eps Forward | -0.55 |
| Eps Trailing Twelve Months | -1.65 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 973 290 9171 |
| Fifty Day Average | 6.4539 |
| Fifty Day Average Change | 0.04610014 |
| Fifty Day Average Change Percent | 0.0071429894 |
| Fifty Two Week Change Percent | -0.15360713 |
| Fifty Two Week High | 8.64 |
| Fifty Two Week High Change | -2.1400003 |
| Fifty Two Week High Change Percent | -0.24768521 |
| Fifty Two Week Low | 4.16 |
| Fifty Two Week Low Change | 2.3400002 |
| Fifty Two Week Low Change Percent | 0.56250006 |
| Fifty Two Week Range | 4.16 - 8.64 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,529,674,200,000 |
| Float Shares | 5,123,763 |
| Forward Eps | -0.55 |
| Forward P E | -11.818182 |
| Free Cashflow | -2,707,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 83 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.86751 |
| Gross Profits | 27,788,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37105998 |
| Held Percent Institutions | 0.10252 |
| Implied Shares Outstanding | 8,083,558 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,676,419,200 |
| Last Split Factor | 1:15 |
| Long Business Summary | electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey. |
| Long Name | electroCore, Inc. |
| Market | us_market |
| Market Cap | 52,543,128 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_224595724 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -13,966,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 52,543,127 |
| Number Of Analyst Opinions | 5 |
| Open | 6.73 |
| Operating Cashflow | -8,187,000 |
| Operating Margins | -0.31819 |
| Payout Ratio | 0.0 |
| Phone | 888 903 2673 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 6.5 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 6.68 |
| Price Hint | 2 |
| Price To Book | -30.37383 |
| Price To Sales Trailing12 Months | 1.6403325 |
| Profit Margins | -0.436 |
| Quick Ratio | 1.114 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.18 |
| Regular Market Change Percent | -2.69461 |
| Regular Market Day High | 7.04 |
| Regular Market Day Low | 6.45 |
| Regular Market Day Range | 6.45 - 7.04 |
| Regular Market Open | 6.73 |
| Regular Market Previous Close | 6.68 |
| Regular Market Price | 6.5 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 33,098 |
| Return On Assets | -0.42008 |
| Return On Equity | -4.78698 |
| Revenue Growth | 0.312 |
| Revenue Per Share | 3.776 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 8,083,558 |
| Shares Percent Shares Out | 0.0361 |
| Shares Short | 291,996 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 261,497 |
| Short Name | electroCore, Inc. |
| Short Percent Of Float | 0.0382 |
| Short Ratio | 4.71 |
| Source Interval | 15 |
| State | NJ |
| Symbol | ECOR |
| Target High Price | 25.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 19.8 |
| Target Median Price | 22.0 |
| Total Cash | 11,611,000 |
| Total Cash Per Share | 1.436 |
| Total Debt | 9,403,000 |
| Total Revenue | 32,032,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.65 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.79145 |
| Two Hundred Day Average Change | 0.70855 |
| Two Hundred Day Average Change Percent | 0.12234414 |
| Type Disp | Equity |
| Volume | 33,098 |
| Website | https://www.electrocore.com |
| Zip | 7,866 |